Tag Archives: Hilary Sloan

Aphria Liberty Health sale agreement

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

Liberty Health Sciences Applauds CSA Notice Regarding Issuers With U.S. Cannabis Investments

TORONTO, Ontario, Feb. 9, 2018 /Weed Wire/ – Liberty Health Sciences Inc. (CSE: LHS or US OTCQX: LHSIF) (the “Company” or “Liberty”) is providing the following statement in response to the Canadian Securities Administration’s (the “CSA”) Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities (the “Notice”), revised February 8, 2018.

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces New Strategic Investors With Proven Investment Experience In Cannabis Industry

TORONTO, Ontario, Feb. 5, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) is pleased to announce today that a group of buyers led by members of the Serruya family (the “Group”) has entered into a purchase and sale agreement with Aphria Inc.

Aphria Liberty Health sale agreement

Liberty Health Sciences Announces Definitive Agreement For The Acquisition Of A 387-Acre Parcel Of Land In Gainesville, Florida

TORONTO, Ontario, Jan. 31, 2018 /Weed Wire/ — Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) announced today that it has entered into a definitive share purchase agreement (the “Definitive Agreement”) with 242 Cannabis Canada Ltd. to acquire all of the issued and outstanding shares (the “Purchased Shares”) of its wholly-owned subsidiary, 242 Cannabis, LLC, a Florida limited liability company, which includes a 387-acre parcel of land in Gainesville, Florida (the “Property”) which was previously owned by Alico Citrus Nursery, LLC, a Florida limited liability company (“Alico”).


Top